Latest Fludeoxyglucose Stories
CULVER CITY, Calif., July 7, 2011 /PRNewswire/ -- Sofie Biosciences, developer of molecular imaging systems and probes, has been awarded a 2011 Phase I Small Business Innovation Research grant from the Department of Energy.
SAN ANTONIO, June 7, 2011 /PRNewswire/ -- Presented today at the Society of Nuclear Medicine 2011 Annual Meeting researchers from Swedish Medical Center and the University of Washington showed that FDG dose for Positron Emission Mammography (PEM) may be reduced by at least 50% without altering image quality. PEM is the breast application of the Naviscan high-resolution PET scanner showing the location as well as the metabolic phase of a lesion.
PET and CT scans, which shows images of both functional and anatomical changes in the body, are useful for viewing ovarian cancer before any operations are done.
WARRENDALE, Pa., May 19, 2011 /PRNewswire/ -- MEDRAD, INC., a business of Bayer HealthCare, has announced the launch of the next generation Intego(TM) PET Infusion System, which features a new design that is 38% smaller, power-driven and includes enhancements to technologist workflow.
Combining computerized tomography (CT) with fluorodeoxyglucose positron emission tomography (FDG-PET) images results in significantly more defined tumor outlines and potentially different treatment options in head and neck cancer patients compared to using CT alone.
For the first time, quantitativeâ€”not qualitativeâ€“ data analysis has demonstrated that time-of-flight (TOF) positron emission tomography (PET) scans can improve cancer detection.
WEARE, N.H., Feb.
Sudden, catastrophic childhood epilepsy is a parent's worst nightmare, especially in the case of fever-induced refractory epileptic encephalopathy in school-age children (FIRES).
A study published in the December issue of The Journal of Nuclear Medicine identified positron emission tomography/computed tomography (PET/CT) scans as a potentially useful tool for predicting local recurrence in lung cancer patients treated with radiofrequency ablation (RFA).
WARRENDALE, Pa., Nov. 29, 2010 /PRNewswire/ -- MEDRAD, Inc. a business of Bayer HealthCare, today announces the U.S. launch of VirtualCAREÂ®, for the MEDRAD Intego(TM) PET Infusion System.